Nadia Liassine

3.2k total citations · 1 hit paper
32 papers, 2.4k citations indexed

About

Nadia Liassine is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Nadia Liassine has authored 32 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Molecular Medicine. Recurrent topics in Nadia Liassine's work include Antimicrobial Resistance in Staphylococcus (15 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (5 papers). Nadia Liassine is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (15 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (5 papers). Nadia Liassine collaborates with scholars based in Switzerland, France and United Kingdom. Nadia Liassine's co-authors include Jérôme Étienne, François Vandenesch, Michèle Bes, Gérard Lina, Mark C. Enright, M.E. Reverdy, Helen Heffernan, Timothy S. Naimi, Timothy Greenland and Graeme R. Nimmo and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nadia Liassine

31 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide Emergence

2003 1.4k citations François Vandenesch, Mark C. Enright et al. Emerging infectious diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nadia Liassine Switzerland	14	2.1k	1.1k	1.0k	624	410	32	2.4k
M.E. Reverdy France	15	2.6k 1.3×	1.4k 1.2×	1.5k 1.5×	722 1.2×	409 1.0×	32	3.0k
Helen Heffernan New Zealand	19	1.7k 0.8×	938 0.8×	950 0.9×	530 0.8×	431 1.1×	43	2.3k
Jasmine Chaitram United States	7	1.9k 0.9×	1.1k 1.0×	1.0k 1.0×	482 0.8×	294 0.7×	15	2.2k
Gary A. Hancock United States	16	1.8k 0.9×	1.1k 1.0×	844 0.8×	265 0.4×	441 1.1×	19	2.3k
Gregory E. Fosheim United States	13	2.8k 1.3×	1.5k 1.3×	1.0k 1.0×	1.1k 1.8×	716 1.7×	14	3.4k
Mary Beth Perri United States	25	1.4k 0.7×	780 0.7×	441 0.4×	309 0.5×	503 1.2×	51	2.0k
B E Murray United States	20	1.6k 0.8×	773 0.7×	604 0.6×	452 0.7×	590 1.4×	27	2.3k
Xiao Xue Japan	18	3.1k 1.5×	1.6k 1.4×	2.2k 2.2×	515 0.8×	314 0.8×	22	3.3k
Marie Hallin Belgium	27	1.4k 0.7×	668 0.6×	747 0.7×	233 0.4×	436 1.1×	81	1.9k
Duarte C. Oliveira Portugal	23	3.8k 1.8×	2.2k 1.9×	2.6k 2.6×	705 1.1×	434 1.1×	33	4.1k

Countries citing papers authored by Nadia Liassine

Since Specialization

Citations

This map shows the geographic impact of Nadia Liassine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia Liassine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia Liassine more than expected).

Fields of papers citing papers by Nadia Liassine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia Liassine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia Liassine. The network helps show where Nadia Liassine may publish in the future.

Co-authorship network of co-authors of Nadia Liassine

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia Liassine. A scholar is included among the top collaborators of Nadia Liassine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia Liassine. Nadia Liassine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schrenzel, Jacques, et al.. (2024). Résurgence de [i]Mycoplasma pneumoniae[/i] : nouvelle épidémie ?. Revue Médicale Suisse. 20(895). 2093–2098. 1 indexed citations

Nunes, Alexandra, Mónica Oleastro, Nadia Liassine, et al.. (2023). Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants. Microbiology Spectrum. 11(4). e0107023–e0107023. 8 indexed citations

Blanc, Dominique, Bruno Grandbastien, Frank Bally, et al.. (2022). [i]Staphylococcus aureus[/i] résistant à la méticilline : 15 ans de surveillance moléculaire en Suisse romande. Revue Médicale Suisse. 18(777). 724–728.

Schwendener, Sybille, et al.. (2021). Methicillin-resistant Macrococcus canis in a human wound. Infection Genetics and Evolution. 96. 105125–105125. 10 indexed citations

Liassine, Nadia, et al.. (2016). Very low prevalence of MCR-1/MCR-2 plasmid-mediated colistin resistance in urinary tract Enterobacteriaceae in Switzerland. International Journal of Infectious Diseases. 51. 4–5. 61 indexed citations

Isnard, Christophe, Reto Lienhard, Sonia Rodrı́guez, et al.. (2015). In vitro antimicrobial susceptibility of Alloscardovia omnicolens and molecular mechanisms of acquired resistance. Diagnostic Microbiology and Infectious Disease. 84(3). 227–229. 8 indexed citations

Huttner, Angela, Elodie von Dach, Nadia Liassine, et al.. (2013). P060: Surveillance and control of community-associated methicillin-resistant Staphylococcus aureus in Geneva, Switzerland, 2002 – 2012. Antimicrobial Resistance and Infection Control. 2(S1). 1 indexed citations

Pastore, Roberta, et al.. (2008). A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005. Swiss Medical Weekly. 138(1516). 243–246. 8 indexed citations

Garnier, Fabien, Anne Tristan, Bruno François, et al.. (2007). Pneumonia and new methicillin-resistant Staphylococcus aureus clone.. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations

10.

Liassine, Nadia, et al.. (2007). Évaluation du test IDI-MRSA sur une collection de souches de Staphylococcus aureus résistants à la méticilline d'acquisition communautaire et sur des prélèvements de portage. Pathologie Biologie. 55(8-9). 378–381. 4 indexed citations

11.

Durand, G., Michèle Bes, H. Meugnier, et al.. (2006). Detection of New Methicillin-Resistant Staphylococcus aureus Clones Containing the Toxic Shock Syndrome Toxin 1 Gene Responsible for Hospital- and Community-Acquired Infections in France. Journal of Clinical Microbiology. 44(3). 847–853. 107 indexed citations

12.

Garnier, Fabien, Anne Tristan, Bruno François, et al.. (2006). Pneumonia and New Methicillin-resistantStaphylococcus aureusClone. Emerging infectious diseases. 12(3). 498–500. 50 indexed citations

13.

Toutous‐Trellu, Laurence, Marc Péchère, Stéphane Hugonnet, et al.. (2005). Increased Incidence of Sexually Transmitted Infections in Geneva, Switzerland. Dermatology. 212(1). 41–46. 15 indexed citations

14.

Liassine, Nadia, et al.. (2004). Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated in Switzerland Contains the Panton-Valentine Leukocidin or Exfoliative Toxin Genes. Journal of Clinical Microbiology. 42(2). 825–828. 101 indexed citations

15.

Schmid, H., A Burnens, A. Baumgärtner, et al.. (2002). Verocytotoxin-Producing Escherichia coli in Patients with Diarrhoea in Switzerland. European Journal of Clinical Microbiology & Infectious Diseases. 21(11). 810–813. 4 indexed citations

16.

Harbarth, Stéphan, et al.. (2000). Risk Factors for Persistent Carriage of Methicillin‐ResistantStaphylococcus aureus. Clinical Infectious Diseases. 31(6). 1380–1385. 157 indexed citations

17.

Liassine, Nadia, et al.. (1999). Antimicrobial Susceptibility of Bacterial Pathogens in the Oropharynx of Healthy Children. European Journal of Clinical Microbiology & Infectious Diseases. 18(3). 217–220. 14 indexed citations

18.

Liassine, Nadia, Reno Frei, Isabelle Jan, & R Auckenthaler. (1998). Characterization of Glycopeptide-Resistant Enterococci from a Swiss Hospital. Journal of Clinical Microbiology. 36(7). 1853–1858. 49 indexed citations

19.

Liassine, Nadia, Jeanine Allignet, Anne Morvan, Sylvie Aubert, & Névine El Solh. (1997). Multiplicity of the Genes and Plasmids Conferring Resistance to Pristinamycin in Staphylococci Selected in an Algerian Hospital. Zentralblatt für Bakteriologie. 286(3). 389–399. 8 indexed citations

20.

Liassine, Nadia, et al.. (1997). In vitro Activity of Cefpirome against Microorganisms Isolated in Haematology, Oncology and Intensive Care Units in Switzerland. Scandinavian Journal of Infectious Diseases. 29(6). 615–621. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact